http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2508185-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C391-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-095 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C391-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095 |
filingDate | 1975-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fadc261df426b0c95d679860fa84fbcd |
publicationDate | 1976-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | DE-2508185-A1 |
titleOfInvention | SELENIUM DERIVATIVES SUITABLE FOR SELENIUM DEFICIENCE THERAPY AND THEIR PREPARATIONS |
abstract | Selenium deficiency in animals is treated by administration of at least one of seleno bis (acetyl L-asparagine), seleno bis (acetyl L-alanine), seleno bis (acetyl L-glutamic acid), seleno bis (acetyl glycine), seleno bis (acetyl L-isoleucine), seleno bis (acetyl L-threonine), seleno bis (acetyl L-valine), seleno bis (L-phenylalanine), seleno bis leucine), seleno bis (acetyl L-tryptophan), seleno bis (acetyl L-tyrosine), seleno bis (propionyl L-valine) and seleno bis (valeryl L-baline). Safe administration of selenium, Selenium deficiency causes exudation diathesis, cardiac degeneration, necrotic liver degeneration and muscular dystrophy. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113105379-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3737566-A1 |
priorityDate | 1975-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.